Effect of withanone and withaferin A purified from WSWE on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Determination of minimum fungicidal concentration of WSWE against <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

WSWE targets both cell wall and cell membrane of <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Micromorphological impact of WSWE treatment on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Proposed model of mode of action of WSWE as anti-fungal agent. by Acharya Balkrishna (5640038)

Subjects:

WSWE treatment reduced total ergosterol amount in <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Subjects:

Excel spreadsheet containing, in separate sheets (for each figure), the underlying numerical datas for Figure panels 1A, 1B, 1C, 2B, 3A, 3B, 3C, 4C, 4D, 4E, 4F, 4G, 5B, 8C and 8D. by Acharya Balkrishna (5640038)

Subjects:

Time kill kinetics of WSWE against <i>S</i>. <i>globosa</i>. by Acharya Balkrishna (5640038)

Subjects:

Trends in antimicrobial resistance and multidrug resistance among <i>Escherichia coli</i> isolated from dog specimens at the Indiana Animal Disease Diagnostic Laboratory, 2010–2019... by John E. Ekakoro (6786596)

Subjects:

CCR Translation for This Article from Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8⁺ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic S... by Marieke F. Fransen (3699181)

VOC Alpha spike protein shows decreased proteolytic processing. by Daniela Niemeyer (199082)

Supplementary Table 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Supplementary Table 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Supplementary Table 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Supplementary Figure 3 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Supplementary Figure 2 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Supplementary Figure 4 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Supplementary Figure 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells by Adam T. Koch (14919645)

Lung tumor development decreases the proportions of CD103⁺XCR1⁺ DC1s. by Julyanne Brassard (4117441)

Hypothetical model of the molecular mechanism underlying the ability of SACMV to suppress the host RNA silencing mechanism (PTGS) and systemic acquired resistance (SAR). by Bulelani L. Sizani (21485746)